Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04018859 · ClinicalTrials.gov registry record · Phase 2
Platelet-rich Plasma for Eyebrows
A Phase 2 study of Eyebrow Hypotrichosis, sponsored by Northwestern University.
- Active
- Registry status
- Phase 2
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT04018859 is a Phase 2 study of Eyebrow Hypotrichosis that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 11 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04018859, a Phase 2 study of Eyebrow Hypotrichosis, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the effect of autologous platelet-rich plasma (PRP) in the treatment of mild to moderate eyebrow hypotrichosis. This is a randomized clinical trial to evaluate the effect of autologous platelet rich plasma in subjects with mild to moderate eyebrow hypotrichosis. Approximately 40 subjects will be randomized to receive platelet-rich plasma (PRP) or saline injections. The study is designed as an 9-month study. This study was a pilot study designed to determine feasibility of this procedure. Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment.
Conditions Studied
Interventions
- DRUG Saline
- DEVICE Platelet Rich Plasma Prep System
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2019-09-25 |
| Est. Completion | 2025-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04018859
The ClinicalTrials.gov registry entry for NCT04018859 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Eyebrow Hypotrichosis appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.
NCT04018859 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT04018859 about?
NCT04018859 is a clinical study titled "Platelet-rich Plasma for Eyebrows". The purpose of this study is to evaluate the effect of autologous platelet-rich plasma (PRP) in the treatment of mild to moderate eyebrow hypotrichosis. This is a randomized clinical trial to evaluate the effect of autologous platelet rich plasma in subjects with mild to moderate eyebrow hypotricho...
What is the current status of trial NCT04018859?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 11 participants. The study started on 2019-09-25. Estimated completion is 2025-12.
What conditions does trial NCT04018859 study?
This clinical trial studies the following conditions: Eyebrow Hypotrichosis.
What interventions are being tested in trial NCT04018859?
The interventions under investigation include: Saline (DRUG), Platelet Rich Plasma Prep System (DEVICE).
Who is sponsoring clinical trial NCT04018859?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04018859 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.